Long-Term Specified Drug Use-Results Survey for Xtandi Capsule
The purpose of this study is to confirm the long term safety and efficacy of enzalutamide in patients.
Castration-resistant Prostate Cancer
DRUG: enzalutamide
Incidences of Adverse Events, Up to 2 years
Overall Survival, Up to 2 years|Change from baseline in PSA value, PSA: prostate-specific antigen, Up to 2 years
The purpose of this study is to confirm the long term safety and efficacy of enzalutamide in patients.